申请人:University of Bath
公开号:US05516788A1
公开(公告)日:1996-05-14
The invention concerns compounds and their enantiomers of the formula IA or IB ##STR1## and pharmaceutically acceptable salts thereof wherein each of R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, R.sup.11 and R.sup.12 is independently selected from hydrogen or an alkyl group containing 1-6 carbon atoms and R.sup.5 is an alkoxy group containing 1-6 carbon atoms. The invention further concerns pharmaceutical compositions comprising the active compounds and methods employing the compounds for the treatment of conditions associated with free radical formation.
本发明涉及化合物及其对映体的公式IA或IB ##STR1##以及其药学上可接受的盐,其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.6、R.sup.7、R.sup.8、R.sup.9、R.sup.10、R.sup.11和R.sup.12中的每一个独立选择自氢或含有1-6个碳原子的烷基基团,而R.sup.5是含有1-6个碳原子的烷氧基团。本发明还涉及包含活性化合物的药物组合物和使用该化合物治疗与自由基形成有关的疾病的方法。